Remote Patient Monitoring: Key Trends, Regional Analysis and Market Forecasts 2023-2027

Table of Contents

1. Market Trends & Strategies

1. Key Takeaways & Strategic Recommendations

• 1.1. Key Takeaways & Strategic Recommendations
• 1.2. Strategic Recommendations

2. Future Market Outlook

• 2.1. Introduction
  • Figure 2.1: Visualisation of Elements in eHealth
  • 2.1.1. Definitions
    • Figure 2.2: Diagram Displaying How Remote Patient Monitoring Works
  • 2.1.2. Devices Used in Remote Patient Monitoring
    • i. Blood Pressure Cuff
    • ii. Glucose Monitoring
      • Figure 2.3: Visualisation of Continuous Glucose Monitor
    • iii. Electrocardiography Devices
    • iv. Heart Rate Monitors
    • v. Fall Detection
    • vi. Smart Scales
      • Figure 2.4: Visualisation of RPM Process Containing Devices Used
  • 2.1.3. Technology Driving Remote Patient Monitoring
    • i. Cellular RPM devices
    • ii. Bluetooth Remote Patient Monitoring Devices
  • 2.1.4. Artificial Intelligence in Remote Patient Monitoring
• 2.2. Benefits of Remote Patient Monitoring
  • 2.2.1. Patient Benefits
    • Figure 2.5: Patient Benefits for Remote Patient Monitoring
    • i. Detailed Information on Personalised Health
    • ii. Faster and Better Access to Healthcare Services
    • iii. Patient Outcomes
    • iv. Comfort in Patients' Own Home
    • v. Better Healthcare Opportunities in Rural Communities
    • vi. Greater Oversight and Communications
  • 2.2.2. Healthcare Professional and Provider Benefits
    • Figure 2.6: Provider Benefits for Remote Patient Monitoring
    • i. Improved Patient Outcomes
    • ii. Lower Costs
    • iii. Free Up Spaces in Hospitals
    • iv. Reduced Risk of Disease Transmission
    • v. Combats Clinical Staff Shortages and Optimises Operations
    • vi. Improves Clinical Decision Making
• 2.3. Disadvantages within Remote Patient Monitoring
  • 2.3.1. Disadvantages of Remote Patient Monitoring for Patients
    • Figure 2.7: Patient Disadvantages for Remote Patient Monitoring
    • i. Patient Isolation
    • ii. Privacy
    • iii. Requires Some Knowledge Surrounding Technology
  • 2.3.2. Disadvantages of Remote Patient Monitoring for Healthcare Providers
    • Figure 2.8: Provider Disadvantages for Remote Patient Monitoring
    • i. Over-reliance on Data
    • ii. Not Consistent Real-Time Monitoring
    • iii. Error Rates of Existing RPM
• 2.4. Drivers of Remote Patient Monitoring
• 2.5. Barriers to Remote Patient Monitoring

3. Market Segments

• 3.1. Introduction
• 3.2. Cardiovascular
  • 3.2.1. Types of Devices Used for Cardiovascular Monitoring
    • i. Blood Pressure Monitor
    • ii. Anticoagulation Testing Devices
      • Figure 3.1: Image Displaying a INR Testing Device
    • iii. ECG devices
      • Figure 3.2: Visualisation of the Kardia Mobile 6L App and Electrode
    • iv. Pulse Oximetry
  • 3.2.2. Other Aspects of Telemedicine Used in Cardiovascular Diseases
  • 3.2.3. The Use of Smartwatches in Cardiovascular Diseases
  • 3.2.4. Changes and Developments in Technology Required
  • 3.2.5. Deployments to Date
    • Figure 3.3: Total Number of Cardiac Patients Using Remote Patient Monitoring (m), Split by 8 Key Regions, 2022-2027
• 3.3. Diabetes
  • 3.3.1. Types of Devices Used for Diabetes Monitoring
    • i. Continuous Glucose Monitor
      • Figure 3.4: Visualisation of Continuous Glucose Monitor
    • ii. Smart Insulin Pen
      • Figure 3.5: Visualisation of Smart Insulin Pen
    • iii. Ketone Monitors
  • 3.3.2. Other Aspects of Telemedicine Used in Diabetes
    • Figure 3.6: Visualisation of Dexcom Clarity
  • 3.3.3. The Use of Smartwatches in Diabetes
  • 3.3.4. Changes and Developments in Technology Required
  • 3.3.5. Deployments to Date
    • Figure 3.7: Total Number of Diabetic Patients Using Remote Patient Monitoring (m), Split by 8 Key Regions, 2022-2027
• 3.4. Obesity
  • 3.4.1. Types of Devices Used for Obesity Management
    • i. Smart Scales
      • Figure 3.8: Visualisation of Smart Scales
    • ii. Blood Pressure Monitors
  • 3.4.2. Other Aspects of Telemedicine in Obesity Monitoring
  • 3.4.3. The Use of Smartwatches in Obesity Monitoring
  • 3.4.4. Changes and Developments Required in Technology
  • 3.4.5. Deployments to Date
    • Figure 3.9: Total Number of Obesity Patients Using Remote Patient Monitoring (m), Split by 8 Key Regions, 2022-2027
• 3.5. Cancer
  • 3.5.1. Types of Devices Used for Cancer Management
    • i. Digital Thermometer
      • Figure 3.10: Visualisation of TempTraq in Remote Patient Monitoring
  • 3.5.2. Other Aspects of Telemedicine in Cancer Management
  • 3.5.3. The Use of Smartwatches in Cancer Management
  • 3.5.4. Changes and Developments Required in Technology
  • 3.5.5. Deployments to Date
    • Figure 3.11: Total Number of Cancer Patients Using Remote Patient Monitoring (m), Split by 8 Key Regions, 2022-2027
• 3.6. Maternity
  • Table 3.12: Vital Sign Uses in Tracking Maternity Clinical Implications
  • 3.6.1. Types of Devices Used for Maternity Management
    • i. Blood Pressure Monitors
  • 3.6.2. Other Aspects of Telemedicine in Maternity Management
    • Figure 3.13: Telemedicine Uses Within Pregnancy
  • 3.6.3. Use of Smartwatches in Maternity Management
  • 3.6.4. Changes and Developments Required in Technology
  • 3.6.5. Deployments to Date
• 3.7. Foetal and Neonatal
  • 3.7.1. Types of Devices Used for Foetal and Neonatal Management
  • 3.7.2. Other Aspects of Telemedicine in Foetal and Neonatal Management
  • 3.7.3. The Use of Smartwatches in Foetal and Neonatal Management
  • 3.7.4. Changes and Developments Required in Technology
  • 3.7.5. Deployments to Date

4. Regional Analysis

• 4.1. Introduction
  • 4.1.1. North America
    • i. US
      • Table 4.1: Key Health Metrics, 2020-2022 US
    • ii. Canada
      • Table 4.2: Key Health Metrics, 2020-2022 Canada
  • 4.1.2. Latin America
    • i. Argentina
      • Table 4.3: Key Health Metrics, Argentina, 2020-2022
    • ii. Brazil
      • Table 4.4: Key Health Metrics, 2020-2022, Brazil
  • 4.1.3. West Europe
    • i. Denmark
      • Table 4.5: Key Health Metrics, 2020-2022, Denmark
    • ii. France
      • Table 4.6: Key Health Metrics, 2020-2022, France
    • iii. Germany
      • Table 4.7: Key Health Metrics, 2020-2022, Germany
    • iv. UK
      • Table 4.8: Key Health Metrics, 2020-2022, UK
  • 4.1.4. Central & East Europe
    • i. Poland
      • Table 4.9: Key Health Metrics, 2020-2022, Poland
  • 4.1.5. Far East & China
    • i. China
      • Table 4.10: Key Health Metrics, 2020-2022, China
    • ii. Japan
      • Table 4.11: Key Health Metrics, 2020-2022, Japan
  • 4.1.6. Indian Subcontinent
    • i. India
      • Table 4.12: Key Health Metrics, 2020-2022, India
  • 4.1.7. Rest of Asia Pacific
    • i. Australia
      • Table 4.13: Key Health Metrics, 2020-2022, Australia
    • ii. Singapore
      • Table 4.14: Key Health Metrics, 2020-2022, Singapore
  • 4.1.8. Africa & Middle East
    • i. Saudi Arabia
      • Table 4.15: Key Health Metrics, 2020-2022, Saudi Arabia
    • ii. South Africa
      • Table 4.16: Key Health Metrics, 2020-2022, South Africa

2. Competitor Leaderboard

1. Competitor Leaderboard & Vendor Profiles

• Table 1.1: Juniper Research Competitor Leaderboard: Remote Patient Monitoring Vendors Included & Product Portfolio
• Figure 1.2: Juniper Research Leaderboard: Remote Patient Monitoring Vendors
• Table 1.3: Juniper Research Leaderboard: Remote Patient Monitoring Vendors Positioning
• Table 1.4: Juniper Research Leaderboard Heatmap: Remote Patient Monitoring
• 1.1. Remote Patient Monitoring Vendor Profiles
  • 1.1.1. Abbott Laboratories
    • i. Corporate
      • Table 1.5: Abbott Laboratories' Financial Snapshot ($b), FY 2019-2021 (FYE 31st December)
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 1.6: Visualisation of the Abbott Laboratories' RPM Solution
      • Figure 1.7: Visualisation of the LibreView Process
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 1.1.2. AMC Health
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 1.1.3. Biotronik
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 1.8: Biotronik's Remote Patient Monitoring Solution
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 1.1.4. Boston Scientific Corporation
    • i. Corporate
      • Table 1.9: Boston Scientific's Financial Snapshot ($b), FY 2019-2021
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 1.10: Visualisation Showing Boston Scientific's Heart Connect System
      • Figure 1.11: Visualisation of Boston Scientific's Latitude Programming System
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 1.1.5. Drager
    • i. Corporate
      • Table 1.12: Dräger's Financial Snapshot ($b), FY 2020-2021
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 1.13: Visualisation of Dräger's Infinity Gateway Suite
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 1.1.6. Ge HealthCare
    • i. Corporate
      • Table 1.14: GE HealthCare's Financial Snapshot ($b), FY 2019-2021 (FYE 31st December)
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 1.15: Visualisation of GE HealthCare's Mural Virtual Clinical Viewer
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 1.1.7. Masimo
    • i. Corporate
      • Table 1.16: Masimo's Financial Snapshot ($m), FY2021-2022 (FYE 1st January)
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 1.17: Visualisation of Replica Smart Patient Data Management
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 1.1.8. MedM
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 1.18: Visualisation of MedM RPM Software
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 1.1.9. Medtronic
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 1.19: Visualisation of Medtronic Remote Patient Monitoring
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 1.1.10. Omron Corporation
    • i. Corporate
      • Table 1.20: Omron's Financial Snapshot ($m), FY2021-2022 (FYE 1st January)
    • iii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 1.21: Visualisation of Omron VitalSight
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 1.1.11. Orion Health
    • i. Corporate
      • Table 1.22: Orion Health's Financial Snapshot ($m), FY2020-2021 (FYE 31st December)
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 1.1.12. Philips
    • i. Corporate
      • Table 1.23: Philips' Financial Snapshot ($b), FY 2019-2021 (FYE 31st December)
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 1.24: Visualisation of Philip's Enterprise Telehealth Solutions
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 1.1.13. Qure4u
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 1.25: Visualisation of Qure4u's Remote Patient Monitoring Solution
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 1.1.14. Roche
    • i. Corporate
      • Table 1.26: Roche's Financial Snapshot ($b), FY 2020-2021 (FYE 31st December)
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
  • 1.1.15. Vivalink
    • i. Corporate
    • ii. Geographic Spread
    • iii. Key Clients & Strategic Partnerships
    • iv. High-level View of Offerings
      • Figure 1.27: Visualisation of Vivalink Wearable SP02 Sensor
    • v. Juniper Research's View: Key Strengths & Strategic Opportunities
• 1.2. Juniper Research Leaderboard Assessment Methodology
  • 1.2.1. Limitations & Interpretations
    • Table 1.28: Juniper Research Competitor Leaderboard Scoring Criteria

3. Data & Forecasting

1. Introduction & Market Summary

• 1.1. Introduction
  • Figure 1.1: Visualisation of Elements in eHealth
  • 1.1.1. Definitions
    • Figure 1.2: Diagram Displaying how Remote Patient Monitoring Works

2. Forecast Summary

• 2.1. Introduction
• 2.2. Users & Revenue
  • 2.2.1. Total Number of RPM Users
    • Figure & Table 2.1: Total Number of RPM Users (m), Split by 8 Key Regions, 2022-2027
  • 2.2.2. Total Number of RPM Devices in Use
    • Figure & Table 2.2: Total Number of RPM Devices (m), Split by 8 Key Regions, 2022-2027
  • 2.2.3. Total RPM Revenue
    • Figure & Table 2.3: Total RPM Revenue ($m), Split by 8 Key Regions, 2022-2027
• 2.3. RPM Revenue from Each Device
  • 2.3.1. Total Revenue from RPM Devices
    • We expect the total annual revenue from people using RPM to reach $110.3 billion in 2027, up from $71.7 billion in 2023; a CAGR of 13.18% across the forecast period.
    • Figure & Table 2.4: Total Number of RPM devices, Split by 7 Devices, 2022-2027

3. Cardiac Monitoring Market Forecasts

• 3.1. Introduction
• 3.2. Forecast Methodology
  • 3.2.1. Users & Revenue Forecast Methodology
    • Figure 3.1: Cardiac Patient RPM Users & Devices Forecast Methodology
• 3.3. Users & Revenue
  • 3.3.1. Total Number of Cardiac Patients using RPM
    • Figure & Table 3.2: Total Number of Cardiac Patients using RPM (m), Split by 8 Key Regions, 2022-2027
  • 3.3.2. Total Number of RPM Devices Used for Cardiac Monitoring
    • Figure & Table 3.3: Total Number of RPM Devices Used for Cardiac Monitoring (m), Split by 8 Key Regions, 2022-2027

4. Diabetes Monitoring Market Forecasts

• 4.1. Introduction
• 4.2. Forecast Methodology
  • 4.2.1. Users & Revenue Forecast Methodology
    • Figure 4.1: Diabetic Patient RPM Users & Devices Forecast Methodology
• 4.3. Users & Revenue
  • 4.3.1. Total Number of Diabetic Patients Using RPM
    • Figure & Table 4.2: Total Number of Cardiac Patients Using RPM (m), Split by 8 Key Regions, 2022-2027
  • 4.3.2. Total Number of RPM Devices Used for Diabetic Monitoring
    • Figure & Table 4.3: Total Number of RPM Devices Used for Cardiac Monitoring (m), Split by 8 Key Regions, 2022-2027

5. Oncology Monitoring Market Forecasts

• 5.1. Introduction
• 5.2. Forecast Methodology
  • 5.2.1. Users & Revenue Forecast Methodology
    • Figure 5.1: Cancer Patient RPM Users & Devices Forecast Methodology
• 5.3. Users & Revenue
  • 5.3.1. Total Number of Cancer Patients Using RPM
    • Figure & Table 5.2: Total Number of Cardiac Patients Using RPM (m), Split by 8 Key Regions, 2022-2027
  • 5.3.2. Total Number of RPM Devices Used for Cancer Monitoring
    • Figure & Table 5.3: Total Number of RPM Devices Used for Cardiac Monitoring (m), Split by 8 Key Regions, 2022-2027

6. Obesity Monitoring Market Forecasts

• 6.1. Introduction
• 6.2. Forecast Methodology
  • 6.2.1. Users & Revenue Forecast Methodology
    • Figure 6.1: Obesity Patient RPM Users & Devices Forecast Methodology
• 6.3. Users & Revenue
  • 6.3.1. Total Number of Obesity Patients Using RPM
    • Figure & Table 6.2: Total Number of Cardiac Patients Using RPM (m), Split by 8 Key Regions, 2022-2027
  • 6.3.2. Total Number of RPM Devices Used for Obesity Monitoring
    • Figure & Table 6.3: Total Number of RPM Devices Used for Cardiac Monitoring (m), Split by 8 Key Regions, 2022-2027